Viewpoints: Public Health Can Win Back Public Trust; What’s Behind The Ever-Increasing Insurance Costs?
Editorial writers discuss these public health issues.
The independent source for health policy research, polling, and news.
1-20 of 113,170 results
Editorial writers discuss these public health issues.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
The study, published Wednesday, suggested that more former football players had chronic traumatic encephalopathy than previously identified. “The NFL continuously strives to make the game of football safer, including by implementing strategies to reduce concussions and head impacts," the NFL said in response.
Two adults were also sickened, the San Francisco Chronicle reported. Public health officials urge people who visited the popular Brookshire Farms from Oct. 16 through Oct. 26 and then developed gastrointestinal symptoms to seek medical attention. The fall attraction has closed while authorities investigate the source of the infections.
Come April 2027, pregnant patients in Luverne will have to travel 30 miles to access inpatient labor and delivery services, MPR News reports. The news was announced the same day that Minnesota Attorney General Keith Ellison unveiled the Strengthening Rural Maternal Health project, designed to close maternal healthcare gaps across the state.
A study, out Wednesday from AARP, found that the out-of-pocket costs of family caregivers — those who assist disabled, chronically ill, or elderly adults — are 60% more than just five years ago and on average comprise 31% of a caregiver's income, NPR reported.
In an attempt to curb healthcare costs, the Labor Department will require drug middlemen to disclose details on how they get paid, the prices paid for pharmaceuticals, and payments they receive from drugmakers, The Wall Street Journal reported.
The Department of Health and Human Services won't pursue legal action against compounding pharmacies that offer the peptides while the administration determines what rules to put in place to ensure the safety of the products. Plus, the healthcare concerns on the minds of candidates and voters heading into the midterm elections.
Today's early morning highlights from the major news organizations.
Opinion writers delve into these public health topics.
Rare-disease advocates applauded the draft guidance, which the FDA published Tuesday, Stat reported. Also in the news: 340B data demands, a Lyme disease vaccine candidate, and more.
The agreement comes after months of public sparring over whether state employees could continue to see their Atrium doctors, North Carolina Health News and Charlotte Ledger reported. Other health industry news is on a new accessible community clinic, Northwestern Medicine's new Transplant Institute, and more.
Thirteen Senate Democrats allege 10 top insurers used an improper process in terminating qualified enrollees, insufficient notice, and a lack of compliance with consumer protections. The Centers for Medicare & Medicaid Services said the 760,000 enrollments were unauthorized, enrolled through brokers without verified documentation, and that insurers could not identify claims or reach the enrollees, Becker's Hospital Review reported.
Stateline reported that from June 2022 to June 2025, the vast majority of the charges occurred in three states with near-total abortion bans: Oklahoma, Alabama, and South Carolina.
CIDRAP reported on the disparities between wealthy countries and those not so well off in "their ability to finance, procure, distribute, and administer" vaccines. More than 8 million lives around the world, many in poorer countries, could have been prevented by 2022 if the covid vaccine had been rolled out 100 days after the virus was sequenced, the policy brief noted.
President Donald Trump estimates his move to relax regulations on oil and gas company leaks would "save consumers and energy producers $45 billion." Environmental groups point out that companies could harness pollution from leaks and put that energy toward home use. The Biden-era rule had aimed to reduce pollutants that cause health problems.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
The author of the real-world study noted that GLP-1 agents might modulate neuroinflammation and neuronal survival through the gut-brain axis, which could contribute to the lower rates of relapse activity and steroid use, reduced incidence of optic neuritis, and fewer demyelinating events, MedPage Today reported.
© 2026 KFF